RxDoctor Payments Data

Kelsey Gregory

Nurse Practitioner · Fond du Lac, WINPI 1902458177

Payments from drug & device makers

$2,276in general payments, 2019–2025

Across 37 payments — averaging $61.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$695
  • Edwards Lifesciences$421
  • Boehringer Ingelheim$351
  • Abbott$288
  • Actelion Pharmaceuticals US, Inc.$126
  • Alnylam Pharmaceuticals Inc.$107
  • plus $288 from 6 others

What the payments were for

  • Food & beverage$2,276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,276 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$20,846
Medicare patients
109
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor25$16,352
EliquisApixaban28$13,902
JardianceEmpagliflozin15$9,581
Metoprolol Succinate62$987
Amiodarone Hcl36$605
Bumetanide13$394
Potassium Chloride14$391
ClopidogrelClopidogrel Bisulfate32$340
Rosuvastatin Calcium15$233
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$198
Losartan Potassium28$114
Atorvastatin Calcium14$100
Furosemide16$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$23$16,35225 claims
Boehringer IngelheimJardiance$351$9,58115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Fond du Lac

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →